Meta-analysis of resource utilization and costs for inhaled corticosteroid treatment vs. leukotriene modifier treatment for patients with asthma

M Golubiewski; K Spayde; R Stanford; Zeba Khan; Michael Halpern

Meta-analysis of resource utilization and costs for inhaled corticosteroid treatment vs. leukotriene modifier treatment for patients with asthma

Halpern, M., Khan, Z., Stanford, R., Spayde, K., & Golubiewski, M. (2003). Meta-analysis of resource utilization and costs for inhaled corticosteroid treatment vs. leukotriene modifier treatment for patients with asthma. Journal of Family Practice, 52.

Copy citation

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination

Article

Accountability for SRHR in the context of the COVID-19 pandemic

Article

Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa

Meta-analysis of resource utilization and costs for inhaled corticosteroid treatment vs. leukotriene modifier treatment for patients with asthma

Publications Info

Recent Publications

Article

The evolution of minimally invasive tissue sampling in postmortem examination

Article

Accountability for SRHR in the context of the COVID-19 pandemic

Article

Validation of simple dichotomous self-report on prenatal alcohol and other drug use in women attending midwife obstetric units in the Cape Metropole, South Africa

Article

Nicotinic acetylcholine receptor accessory subunits determine the activity profile of epibatidine derivatives